beta

ARCKU

Arbor Rapha Capital Bioholdings Corp I

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

RCM is an investment management firm located in Miami, Florida focused on identifying and managing strategic investments in early stage, non-public biotechnology companies, with a strategy of identifying and growing revolutionary and disruptive ideas in medicine, healthcare, and biotechnology before others can see their value. RCM executes its investment strategy by making equity and convertible debt investments in privately held companies that RCM believes have developed a transformative product, technology, or process that will drive long-term value creation for shareholders. RCM’s portfolio companies currently focus on a wide range of targets, including immunotherapies, medical devices, ocular diseases, genome editing, cell and gene therapy and bioprinting.

Market Cap: 205 Million

Primary Exchange: NASDAQ

Website: arcbiocorp.com

Shares Outstanding: 15 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.0

Sector:

Industry:

Ethical Flags

Longest drawdown: 278 trading days

From: 2022-02-23 To: 2022-12-01

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud